Abstract:Abstract Introduction As not all wounds are amenable to immediate skin grafting, the search for the ideal skin substitute is ever present. The ideal skin substitute would be resistant to infection, inexpensive, readily available, quick to integrate and applicable to a variety of wounds. Here we describe the use of a synthetic polyurethane matrix in the setting of burns and other complex wounds in the largest case series to date. Methods A retrospective review was conducted at a verified, regional burn center. Dual IRB approval was obtained. All patients greater than 18 years of age who received this matrix between January 2019 and July 2023 were included. Data collected included: age, sex, wound etiology, social and medical history, presence of exposed critical structures, presence of infection, length of stay, time to matrix implantation, time to skin graft, percent of matrix survival, percent skin graft survival and disposition. Results A total of 182 patients with 250 wounds were included in this study. The average age was 50.5 ± 18.7 years and 61% were male. Thirty-seven percent were smokers, 23.6% had diabetes and 5.5% had peripheral vascular disease. The majority were acute burn wounds (60%), followed by, trauma (24.4%), chronic wounds (5.6%), infection (4%) and donor sites (2%). Exposed structures included fat (54%), muscle (30%), bone (16%) and tendon (14.4%). Infection was present in 143 (57.2%) of cases: 98 (39.2%) pre-application and 89 (35.6%) post application. The incidence of new infection post-application was 25.6%. The pathogens are detailed in figure 1; several infections were polymicrobial. Eighteen patients (10%) died. Median length of stay was 27 (13.3, 64) days. Median time to matrix implantation was 10 (6, 17) days. And median time from matrix placement to skin grafting was 35 (24.8, 42) days. Where documented, there were 162 wounds (83.5%) with > 95% matrix survival and 136 wounds (82.4%) with > 95% skin graft survival. The patient dispositions are detailed in table 2. Conclusions We describe to date the largest clinical series utilizing a synthetic polyurethane matrix. This matrix was successfully used in a large number of patients with burns, trauma and chronic wounds. Despite the presence of active smoking, diabetes or infection, there was greater than 95% matrix and skin graft survival in more than 80% of patients. This study demonstrates the robustness of this skin substitute to achieve successful reconstruction even in the setting of adverse patient or wound characteristics. Applicability of Research to Practice This study highlights the utility of using a synthetic polyurethane matrix to cover full thickness, difficult to reconstruct wounds secondary to trauma or other injuries. This matrix is resistant to infection and can allow for successful coverage of wounds even in patients who are smokers or have diabetes.

Biodegradable Temporising matrix in the reconstruction of complex wounds: A systematic review and meta‐analysis

The use of NovoSorb biodegradable temporising matrix in wound management: a literature review and case series

Novosorb Biodegradable Temporizing Matrix for Reconstruction of Complex Upper-Extremity Wounds

NovoSorb® biodegradable temporising matrix (BTM) in the reconstruction of cutaneous malignancies in a major cancer centre: a case series

Outcomes of Biodegradable Temporizing Matrix for Soft Tissue Reconstruction of the Hand and Extremities

Reconstruction of Complex Upper Extremity Wounds With Novosorb Biodegradable Temporizing Matrix Versus Integra Collagen-Chondroitin Silicone: A Cost Analysis

Comparative Analysis of Animal-Derived vs Fully Synthetic Acellular Dermal Matrices in Reconstructive Surgery

Bioabsorbable Temporizing Matrix (BTM): Not Just for Burns

NovoSorb® Biodegradable Temporizing Matrix: a novel approach for treatment of extremity avulsion injuries in children

A Unicenter Experience of 175 Cases

Long-term patient-reported functional and cosmetic outcomes following severe traumatic foot and ankle wound reconstruction with acellular dermal matrix

Management of wounds with exposed bone structures using an induced-membrane followed by polymethyl methacrylate and second-stage skin grafting in the elderly with a 3-year follow-up

The use of a multimodal wound matrix to treat a variety of hard-to-heal wounds: a case series surveillance

The Role of Negative Pressure Wound Therapy in Temporizing Traumatic Wounds before Lower Limb Soft Tissue Reconstruction: A Systematic Review

Long-term experience with a collagen-elastin scaffold in combination with split-thickness skin grafts for the treatment of full-thickness soft tissue defects: improvements in outcome—a retrospective cohort study and case report

An Open-Label, Interventional, Prospective, Real-World Evidence Study to Evaluate a Multimodal Wound Matrix in Patients with Refractory Wounds

Ease of use, safety, and efficacy of integra bilayer wound matrix in the treatment of diabetic foot ulcers in an outpatient clinical setting: a prospective pilot study.

604 Single Center 4-year Review of Synthetic Polyurethane Matrix Use in Burns and Other Complex Wounds

Use of a collagen-elastin matrix with split-thickness skin graft for defect coverage in complex wounds

Wound Healing Outcomes Following Treatment With Synthetic Hybrid-Scale Fiber Matrix After Resection of Soft Tissue Tumors or Infections

The use of fetal bovine acellular dermal matrix in severe diabetic foot ulceration and threatened limbs with tissue loss the use of FBADM as an adjunct for complex wounds